| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $40.8M | — | +28.1% |
| R&D Expense | $48.0M | — | -10.5% |
| SG&A Expense | $42.8M | — | -5.1% |
| Operating Income | -$135.8M | — | +11.6% |
| Pre-tax Income | -$127.5M | — | +12.9% |
| Income Tax | -$34.3M | — | +14.6% |
| Net Income | -$93.2M | — | +12.3% |
| EPS (Basic) | -$2.29 | — | +26.1% |
| EPS (Diluted) | -$2.29 | — | +26.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $69.3M | -72.2% | -48.2% |
| Accounts Receivable | $20.3M | +11.2% | +5.4% |
| Current Assets | $877.3M | -8.0% | +20.6% |
| Total Assets | $2.80B | -4.1% | -1.5% |
| Current Liabilities | $74.7M | -6.2% | -0.4% |
| Total Liabilities | $302.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$87.0M | — | +8.4% |
| Capital Expenditures | $503K | — | +711.3% |
| Investing Cash Flow | -$93.4M | — | -739.5% |
| Free Cash Flow | -$87.5M | — | +8.0% |
| -30.2% |
| Stockholders' Equity | $2.50B | -3.0% | +3.6% |